Trials / Completed
CompletedNCT02446353
Pharmacokinetics and Safety Study of Apetrol ES
A Randomized, Open Label, Single Dose, Cross-over, Phase I Trial to Investigate Safety and Pharmacokinetics of Apetrol ES and Megace® Under Fasting and Fed Conditions in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 79 (actual)
- Sponsor
- LG Life Sciences · Industry
- Sex
- Male
- Age
- 20 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A Randomized, Open Label, Single dose, Cross-over, Phase I Trial to Investigate Safety and Pharmacokinetics of Apetrol ES and Megace® in Healthy Male Volunteers.
Detailed description
\[Part 1\] fasting \[Part 2\] fed
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Apetrol ES / Megace | Sequences of administered drugs |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2010-06-01
- Completion
- 2010-10-01
- First posted
- 2015-05-18
- Last updated
- 2015-05-18
Source: ClinicalTrials.gov record NCT02446353. Inclusion in this directory is not an endorsement.